What is LABFF stock price today?

LABFF (Laboratorios Farmaceuticos Rovi, S.A./Adr) stock is trading at $90.61 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is LABFF stock going up or down today?

LABFF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LABFF stock now?

The decision to buy LABFF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LABFF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LABFF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LABFF stock overvalued or undervalued?

LABFF currently trades at a P/E ratio of 28.95, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if LABFF is fairly priced.

What is LABFF's P/E ratio?

LABFF has a price-to-earnings (P/E) ratio of 28.95, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is LABFF's market cap?

LABFF (Laboratorios Farmaceuticos Rovi, S.A./Adr) has a market capitalization of $4.63 billion, making it a small-cap stock.

What is LABFF's price to book ratio?

LABFF trades at a price-to-book (P/B) ratio of 8.75, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does LABFF pay dividends?

LABFF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is LABFF's dividend yield?

LABFF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is LABFF stock a good long-term investment?

LABFF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LABFF's revenue growth rate?

LABFF has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, LABFF is profitable with a profit margin of 0.2%. This indicates the company generates 0.2 cents of profit for every dollar of revenue.

What are the risks of investing in LABFF?

Key risks for LABFF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LABFF compare to its competitors?

Compare LABFF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LABFF's performance and positioning.

What is LABFF's stock price target for 2026?

Our AI model provides price targets for LABFF based on fundamental analysis: Bull case $117.79 (+30%), Base case $104.20 (+15%), Bear case $81.55 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about LABFF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LABFF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LABFF's next earnings report?

LABFF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LABFF - Laboratorios Farmaceuticos Rovi, S.A./Adr

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$90.61

+$0.00 (+0.00%)

About Laboratorios Farmaceuticos Rovi, S.A./Adr

Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express; catheter care under the Fibrilin brand; and Sodium Heparin Rovi. In addition, the company offers contract-manufacturing services comprising compounding, sterile filling and terminal sterilisation, inspection, installation of safety devices, labelling, packaging, serialisation and aggregation, for different injectable pharmaceutical forms, such as prefilled syringes, vials and cartridges, as well as manufacturing and packaging services for solid products. Further, it offers low-molecular-weight heparin, Okedi, and Rolcya; and develops Letrozole SIE and Risperidone QUAR. Its products are used for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. The company was incorporated in 1946 and is headquartered in Pozuelo de Alarcón, Spain. Laboratorios Farmaceúticos Rovi, S.A. operates as a subsidiary of Norbel Inversiones, S.L.

LABFF Key Statistics

Market Cap

$4.63B

P/E Ratio

28.95

P/B Ratio

8.75

EPS

$3.13

Revenue Growth

+0.1%

Profit Margin

0.2%

Employees

1,950

How LABFF Compares to Peers

LABFF is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
LABFF(This stock)	$4.63B	28.9	0%	0.2%	-
LLYEli Lilly	$809.09B	39.3	0%	0.3%	vs LLY
JNJJohnson &	$575.17B	21.8	0%	0.2%	vs JNJ
PFEPfizer Inc	$154.67B	20.0	-0%	0.1%	vs PFE
MRKMerck &	$291.50B	16.2	0%	0.3%	vs MRK
ABBVAbbvie Inc	$368.65B	87.6	0%	0.1%	vs ABBV

Laboratorios Farmaceuticos Rovi, S.A./Adr Company Information

Headquarters: Calle José Isbert, 2, Pozuelo de Alarcón, Spain, 28223, undefined
Website: www.rovi.es
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

About Laboratorios Farmaceuticos Rovi, S.A./Adr

LABFF Key Statistics

How LABFF Compares to Peers

Laboratorios Farmaceuticos Rovi, S.A./Adr Company Information

Upcoming Events for LABFF